Exercise is one of the most powerful, multi‑system interventions in medicine, affecting the cardiovascular and respiratory systems, the bones and muscles, the composition of our bodies, and even our brains. Most of the systemic benefits have been well elucidated in research, but until recently, we didn’t have a good mechanistic rationale for why it so effectively protects the brain, particularly against neurodegenerative disease as we age. But perhaps now we have a clue. For athletes and trainers – especially those who work with older adults as is a growing purview in the MetFix community—this brain-body connection is not just a theoretical curiosity; it’s one more compelling argument for why structured, lifelong movement is a core pillar of healthy aging from head to toe.

That exercise benefits brain health isn’t a new concept; population and cohort studies have consistently shown that regular aerobic exercise lowers dementia risk and slows cognitive decline, with proposed mechanisms including improved cerebrovascular function, reduced neuroinflammation, and better BBB integrity. Recent research by Bieri et al., published in March 2026 in Cell, points to the latter theory and to a plausible new mechanism for how exercise might work to revitalize the blood–brain barrier via a particular liver exerkine, an exercise‑induced liver enzyme with the unwieldy name glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1).

The research was done in mice, not humans, and the caveat there is always that mice are not just furry little four-legged humans. Their physiology is often not analogous, but the GPLD1 enzyme and the specific protein it targets on the BBB in mice both do exist in humans. And human studies have shown that plasma levels of GPLD1 rise with exercise by up to 50% in elderly subjects versus their sedentary counterparts, which parallels the mouse data, and there is further indirect human evidence to suggest that the mouse data might translate to humans.

For example, a randomized trial in older adults with mild cognitive impairment (MCI) showed that a year of moderate aerobic exercise increased cerebral blood flow and reduced carotid vessel stiffness, changes that are consistent with better cerebral vascular health and thus a more resilient BBB, even though parameters of the BBB itself were not directly measured.

And a 2022 study in elderly women found that 12 weeks of exercise training reduced serum S100β, a blood biomarker associated with BBB disruption, while increasing both BDNF (brain-derived neurotrophic factor, a sort of ‘growth fertilizer’ for neurons) and antioxidant‑related sirtuins (enzymes crucial for metabolic homeostasis that enhance DNA repair, combat oxidative stress, and regulate cellular health), and these actions were interpreted by the authors as evidence that exercise lowered BBB permeability and improved neurovascular health. Again, indirect, but interesting.

The blood–brain barrier and why it matters

The BBB is a specialized vascular interface that tightly controls what passes from the bloodstream into the brain. And the health of the brain depends upon it. It’s formed by endothelial cells (which line blood vessels) that are sealed one to another with tight junctions and a surrounding network of small vessels. With age, the tightly protective seal of the BBB gradually becomes weaker and leakier, which allows potentially neurotoxic molecules, chemicals, inflammatory mediators, proteins, and immune cells easier access into the brain.

Dysfunction of the barrier is increasingly linked to cognitive decline, Alzheimer’s‑related pathology, and vascular‑type dementia. A leaky BBB promotes brain aging by letting pro‑inflammatory signals and potentially neurotoxic molecules in while impairing the brain’s ability to get metabolic waste out, including such infamous substances as amyloid‑β. Like loss of muscle mass and bone mass, weakening of the BBB has been, to a degree, viewed as an expected consequence of aging, but perhaps it doesn’t have to be. And that’s why the recent discovery that exercise can stabilize or strengthen the aging BBB (just as it does the aging musculoskeletal system) is so clinically important, even if at present it’s only shown definitively in mice.

Of Mice and Men (or Women)

The Cell paper that kicked off this discussion describes a liver‑derived enzyme called GPLD1 that is shed into the blood during exercise. In aging and Alzheimer’s mouse models, circulating GPLD1 was seen to reach the brain vasculature and selectively cleave a molecule called TNAP (tissue‑nonspecific alkaline phosphatase), which is a protein on the surface of brain‑barrier cells. The presence of TNAP is associated with BBB leakiness and vascular inflammation; when it was reduced by GPLD1 cleavage or by pharmacologic inhibition, the BBB became less permeable, inflammation dropped, and cognitive performance improved.

Strictly speaking, the direct mechanistic chain—exercise leads to a rise in GPLD1 in the blood, which increases TNAP cleavage, which makes the BBB structurally tighter, which improves cognition—has been demonstrated in mice, but not yet in humans. However, the pieces of the human puzzle are starting to fall into place.

Although we don’t yet have in vivo imaging proof that exercise structurally tightens the human BBB in exactly the same way as it does in mice, the indirect evidence is strong and consistent. And if it pans out, exercising athletes (of any age or ability) won’t just improve muscle strength, bone density, and aerobic capacity, they’ll in effect be running a BBB remodeling program that will rejuvenate their cognitive health as well. A good reminder that exercise is not just about strength, speed, power, or endurance, it’s also (and perhaps even more crucially) a powerful systemic vascular and neuroprotective therapy.

Of course consistent commitment to the variable demands imposed by the MetFix nutrition and exercise methodology reaps well-documented benefits that reach far beyond the brain—including improved metabolic health (insulin sensitivity, glucose disposal, and fat oxidation), improved cardiovascular fitness (improved cardiac output, reduced vascular stiffness, better coronary perfusion, improved endothelial function), better systemic oxygen delivery (better oxygen uptake, increased VO2Max, improved work capacity for perceived exertion), better sleep, greater resilience to stress and infection, reduced inflammation, mood stabilization, and increased bone density and muscle mass. The long list could go on, but you’re likely well acquainted with these many benefits.

We’ve long understood that exercise trains the body, but it also trains the brain by tuning the immune system, optimizing metabolic, cardiovascular, and respiratory health—and perhaps by strengthening the blood-brain barrier. For cross‑training athletes, that means every workout is really a systemic tune‑up, not just a session on the clock. The takeaway is straightforward: exercise is a multi‑system, low‑cost, high‑yield therapy that hits the cardiovascular system, the metabolic machinery, the immune system, mood, and sleep simultaneously. And may even rejuvenate the BBB. This new GPLD1 work adds a compelling new mechanistic layer to the old axiom that exercise is good medicine… but you already knew that.